盐酸伊立替康脂质体（Ⅱ）二线治疗局部晚期或转移性胰腺癌的成本-效果分析
向左娟, 陈小娟, 付滢舟
Cost-effectiveness analysis of irinotecan hydrochloride liposome （Ⅱ） as a second-line treatment for locally advanced or metastatic pancreatic cancer
XIANG Zuojuan, CHEN Xiaojuan, FU Yingzhou
中国医院药学杂志
.
2025, (16): 1875
-1880
.
DOI: 10.13286/j.1001-5213.2025.16.09
